ClinicalTrials.Veeva

Menu

The Diagnostic and Prognostic Value of Speckle Tracking Imaging in Septic Cardiomyopathy

Fudan University logo

Fudan University

Status

Enrolling

Conditions

Echocardiography
Cardiomyopathies
Sepsis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to explore if STI technology, especially TMAD, plays an important role in evaluating left ventricular longitudinal systolic function and discriminating SICM in patients with sepsis. The investigators also intend to prove that TMAD may have predictive value in patients with sepsis, which is worthy of in-depth study to find strong evidence-based medical evidence for subsequent clinical practical applications.

Full description

In order to explore if STI technology, especially TMAD, plays an important role in evaluating left ventricular longitudinal systolic function and discriminating SICM in patients with sepsis, the investigators intend to explore that TMAD may have predictive value in patients with sepsis, which is worthy of in-depth study to find strong evidence-based medical evidence for subsequent clinical practical applications.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who are diagnosed as sepsis according to sepsis 3.0 criteria

Exclusion criteria

  • patients with history of organic heart disease;
  • patients with history of heart failure
  • holder of cardiac implanted device;
  • patients with history of atrial fibrillation;
  • refusal to participate in the study

Trial contacts and locations

1

Loading...

Central trial contact

Jieqiong Song

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems